Review
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Mar 7, 2017; 23(9): 1552-1567
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1552
Current knowledge on the laboratory diagnosis of Clostridium difficile infection
Adrián Martínez-Meléndez, Adrián Camacho-Ortiz, Rayo Morfin-Otero, Héctor Jesús Maldonado-Garza, Licet Villarreal-Treviño, Elvira Garza-González
Adrián Martínez-Meléndez, Licet Villarreal-Treviño, Departamento de Microbiología e Inmunología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León. Pedro de Alba S/N, Ciudad Universitaria, San Nicolás de los Garza, Nuevo León 66450, Mexico
Adrián Camacho-Ortiz, Servicio de Infectología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León. Av. Francisco I. Madero Pte. S/N, Col. Mitras Centro. Monterrey, Nuevo Leon 64460, Mexico
Rayo Morfin-Otero, Hospital Civil de Guadalajara, "Fray Antonio Alcalde" e Instituto de Patología Infecciosa y Experimental, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Sierra Mojada 950, Col. Independencia, Guadalajara, Jalisco 44350, Mexico
Héctor Jesús Maldonado-Garza, Elvira Garza-González, Servicio de Gastroenterología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León. Av. Francisco I. Madero Pte. S/N, Col. Mitras Centro. Monterrey, Nuevo Leon 64460, Mexico
Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version.
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Elvira Garza-González, PhD, Servicio de Gastroenterología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León. Av. Francisco I. Madero Pte. S/N, Col. Mitras Centro. Monterrey, Nuevo Leon 64460, Mexico. elvira_garza_gzz@yahoo.com
Telephone: +52-81-83333664 Fax: +52-81-83294166
Received: November 15, 2016
Peer-review started: November 15, 2016
First decision: January 10, 2017
Revised: January 21, 2017
Accepted: February 16, 2017
Article in press: February 17, 2017
Published online: March 7, 2017
Abstract

Clostridium difficile (C. difficile) is a spore-forming, toxin-producing, gram-positive anaerobic bacterium that is the principal etiologic agent of antibiotic-associated diarrhea. Infection with C. difficile (CDI) is characterized by diarrhea in clinical syndromes that vary from self-limited to mild or severe. Since its initial recognition as the causative agent of pseudomembranous colitis, C. difficile has spread around the world. CDI is one of the most common healthcare-associated infections and a significant cause of morbidity and mortality among older adult hospitalized patients. Due to extensive antibiotic usage, the number of CDIs has increased. Diagnosis of CDI is often difficult and has a substantial impact on the management of patients with the disease, mainly with regards to antibiotic management. The diagnosis of CDI is primarily based on the clinical signs and symptoms and is only confirmed by laboratory testing. Despite the high burden of CDI and the increasing interest in the disease, episodes of CDI are often misdiagnosed. The reasons for misdiagnosis are the lack of clinical suspicion or the use of inappropriate tests. The proper diagnosis of CDI reduces transmission, prevents inadequate or unnecessary treatments, and assures best antibiotic treatment. We review the options for the laboratory diagnosis of CDI within the settings of the most accepted guidelines for CDI diagnosis, treatment, and prevention of CDI.

Keywords: Clostridium difficile, Toxigenic culture, Nucleic acid amplification tests, Enzyme immunoassay, Diagnosis, Glutamate dehydrogenase

Core tip: This work is a review of the strategies that may be used for laboratory diagnosis of infection with Clostridium difficile. First, we provide general recommendations for testing of samples taking in account the guidelines of the Society for Healthcare Epidemiology of America/Infectious Diseases Society of America and the American College of Gastroenterology. We reviewed diverse methods of diagnosis including, culture, toxigenic culture, cell cytotoxic neutralization assay and the use of enzyme immuno assays. Finally, we present an overview of singleplex and multiplex nucleic acid amplification tests.